France· FR:64447081
CUROSURF 240 mg/3 ml, suspension pour instillation endotrachéobronchique
A medicinal product containing poractant alfa, registered in France by CHIESI.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PORACTANT ALFA
- Manufacturer
- CHIESI
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009557753791 flacon(s) en verre de 3 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Poractant alfa in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCurosurfOrifarm Oy
- SwedenCurosurf 80 mg/ml Instillationsvätska för luftvägarna, suspensionChiesi Farmaceutici S.p.A.
- IrelandCUROSURF 120 mg/vial Endotracheopulmonary instillation, suspensionChiesi Farmaceutici S.p.A.
- PolandCurosurfDelfarma Sp. z o.o.
- United KingdomCurosurf 120mg/1.5ml endotracheopulmonary suspension vialsChiesi Ltd
- United StatesCurosurfChiesi USA, Inc.
- GermanyCurosurfChiesi Gmbh
- NorwayCurosurfChiesi Farmaceutici S.p.a.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Curosurf
- Belgium · Curosurf
- Bulgaria · Куросърф
- Cyprus · Curosurf
- Czechia · Curosurf
- Denmark · Curosurf
- Estonia · Curosurf
- Spain · Curosurf
- Finland · Curosurf
- United Kingdom (Northern Ireland) · Curosurf
- Greece · Curosurf
- Croatia · Curosurf
- Hungary · Curosurf
- Ireland · Curosurf
- Iceland · Curosurf
- Italy · Curosurf
- Lithuania · Curosurf
- Luxembourg · Curosurf
- Latvia · Curosurf
- Malta · Curosurf
- Netherlands · Curosurf
- Norway · Curosurf
- Poland · Curosurf
- Portugal · Curosurf
- Romania · Curosurf
- Sweden · Curosurf
- Slovenia · Curosurf
- Slovakia · Curosurf
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5756058-6b68-46a7-9063-7d0d88b13874 GET /v1/drugs/c5756058-6b68-46a7-9063-7d0d88b13874?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64447081",
"date_amm": "1992-08-06",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "PORACTANT ALFA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension pour instillation",
"voies_administration": "endotrachéobronchique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about poractant alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.